ORION
News
ORION Clinical Services CELEBRATES 10 years providing services to the Drug Development Community
Orion was founded in the UK in 1997 and has grown organically with no mergers, acquisitions or injections of external capital. ORION has expanded from a handful of staff in a small office to the present day with over 200 personnel worldwide, with our staff based either regionally or in one of our main offices in Slough (UK); Paris (France); Cologne (Germany); Melbourne (Australia) and New Jersey (USA).
Our objective has been to develop the organization by working with a core group of clients from whom we get repeat business and who recommend us to their colleagues who work for other potential sponsors.
Orion believes that the values we encourage in our employees: trust, integrity, honesty, accountability and quality have led us to grow and deliver over the last decade and which we will continue to deliver into the future.
Dr. Fabrice Chartier, Scientific Director and COO
“During the last 10 years, the CRO industry has continued to evolve, creating market conditions that required us to take a dynamic and creative approach in the way we run our business. Much of our success is owed to the fact we were able to assemble project teams exactly adapted to the needs of the clinical trials contracted to us, utilizing a combination of local operations and central expertise, becoming a unique, quality-driven Contract Research Organization and developing our capabilities in North America, Europe and Australasia."
Dr Alan Irvine, Medical Director and CEO:
“ORION at its 10 year anniversary retains all the original qualities Fabrice Chartier and I sought from the outset. The company has clearly grown very significantly from its inception in 1997 but remains human sized and committed to quality and client satisfaction. We strive to be flexible, proactive and focused at all times on our clients’ objectives and goals. We work particularly with challenging products and indications such as oncology, immunology or critical care. Our client base ranges from big pharma to emerging companies and we are delighted to have a very high level of repeat business. Our key strength has always been and remains the quality and commitment of our staff worldwide.”